There is a need to develop human hepatocyte cell lines which retain both replicating capacity and highly differentiated functions to facilitate the development of an efficient bioartificial liver. The present study was undertaken to differentiate, using sodium butyrate, the actively replicating immortalized human liver cell line.
The effects of butyrate on cell growth and cell cycle were analyzed, and the albumin synthesis, cytochrome P450 and ammonia-detoxifying activity of the butyrate-treated cells were measured. Butyrate treatment resulted in G2/M arrest of the cell cycle and polygonal changes in the cell morphology. Neither the control nor the butyrate-treated cells showed transformed characteristics. Butyrate treatment increased the amount of albumin secretion, cytochrome P450 activity, and the urea production rate of the cells.
The present study provides non-transformed human hepatocytes, which can replicate unlimitedly and then restore differentiated hepatocyte-specific functions by butyrate, and therefore, have applications for the development of an efficient bioartiflcial liver
RozgaJ., WilliamsF., RoM.S.. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells.Hepatology1993; 17: 258–65.
2.
NybergS.L., PeshwaM.V., PayneW.D., HuW.S., CerraF.B.. Evolution of the boartificial liver: the need for randomized clinical trials.Am J Surg1993; 166: 512–21.
3.
HughesR.D., WilliamsR.. Assessment of bioartificial liver support in acute liver failure.Int J Artif Organs1996; 19: 3–6.
RiordanS., WillamsR.. Bioartificial liver support: developments in hepatocyte culture and bioreactor design.Br Med Bull1997; 53: 730–44.
6.
StangeJ., MitznerS., StraussM.. Primary or established liver cells for a hybrid liver? Comparison of metabolic features.ASAIO J1995; 41: M310–5.
7.
EnosawaS., SuzukiS., KakefudaT., AmemiyaH.. Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines.Cell Transplant1996; 5: S39–40.
8.
NybergS.L., RemmelR.P., MannH.J., PeshwaM.V., HuW.S., CerraF.B.. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.Ann Surg1994; 220: 59–67.
9.
te VeldeA.A., FlendrigL.M., LadigesN.C., ChamuleauR.A.. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure.Int J Artif Organs1997; 20: 229–33.
10.
ArkadopoulosN., DetryO, RozgaJ., DemetriouA.A.. Liver assist systems: state of the art.Int J Artif Organs1998; 21: 781–7.
11.
TadaS., SaitoH., EbinumaH.. Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrate.Cancer Biochem Biophys1996; 15: 179–88.
12.
SaitoH., TadaS., EbinumaH.. Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.J Gastroenterol1994; 29: 733–9.
13.
SaitoH., MorizaneT., WatanabeT.. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-TInt J Cancer1991; 48: 291–6.
14.
SaitoH., KagawaT., TadaS.. Effect of dexamethasone, dimethylsulfoxide and sodium butyrate on human hepatoma cell line PLC/PRF/5.Cancer Biochem Biophys1996; 15: 179–88.
15.
LederA., LederP.. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells.Cell1975; 5: 319–22.
16.
GumJ.R., KamW.K., ByrdJ.C., HicksJ.W., SleisengerM.H., KimY.S.. Effect of sodium butyrate on human colonic adenocarcinoma cells: induction of placental-like alkaline phosphatase.J Biol Chem1987; 262: 1092–7.
17.
LangdonS.P., HawkesM.M., HayF.G.. Effect of sodium butyrate and other differentiation inducer on poorly differentiated human ovarian adenocarcinoma cell lines.Cancer Res1988; 48: 6161–5.
18.
TsutsumiT., IdoA., NakaoK.. Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.Gastroenterology1994; 107: 499–504.
19.
BartalenaL., BogazziF., DonadelG., MartinoE., GabrielliF., PincheraA.. The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells.J Endocrinol Invest1990; 13: 917–22.
20.
ParkJ., LeeH-S, ParkJ.B., KimC.Y.. Establishment of continuous human fetal hepatocyte cell line by transfection of simian virus 40 T gene.Mol Cells1996; 6: 534–40.
21.
NicolettiI., MiglioratiG., PagliacciM.C., GrignaniF., RiccardiC.. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.J Immunol Methods1991; 139: 271–9.
22.
KonoY., YangS., LetarteM., RobertsE.A.. Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system.Exp Cell Res1995; 221: 478–85.
23.
NiwaY., MatsumuraM., ShiratoriY.. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.Hepatology1996; 23: 1384–92.
24.
MatsumuraM., NiwaY., HikibaY.. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.Biochem Biophys Res Commun1995; 207: 813–8.
25.
Kowalski-SaundersP.W., WinwoodP.J., ArthurM.J.P., WrightR.. Reversible inhibition of albumin production by rat hepatocyte maintained on a laminin-rich gel (Engelbreth-Holm-Swarm) in response to secretory products of Kupffer cells and cytokines.Hepatology1992; 16: 733–41.
26.
MolowaD.T., SchuetzE.G., WrightonS.A.. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver.Proc Natl Acad Sci USA1986; 83: 5311–5.
27.
LennardM.S., CreweH.K., TuckerG.T., WoodsH.F.. Metoprolol oxidation by rat liver microsomes. Inhibition by debrisoquine and other drugs.Biochem Pharmacol1986; 35: 2757–61.
28.
FreshneyR.I.. Culture of animal cells.3rd ed.New York: Wley-Liss, 1994; 91–3.
29.
SalyersA.A., LeedleJ.A.Z.. Carbohydrate metabolism in the human colon. In: HentgesD.J., ed. Human intestinal microflora in health and disease.New York: Academic, 1983; 129–46.
30.
CummingsJ.H., PomareE.W., BranchW.J., NaylorC.P.E.. Short chain fatty acids in human intestine, portal, hepatic and venous blood.Gut1987; 28: 1221–7.
31.
DanielP., BrazierM., CeruttiI.. Pharmacokinetic study of butyric acid administrated in vivo as sodium and arginine butyrate salts.Clin Chim Acta1989; 181: 255–64.
32.
WangX-M, WangX., LiJ., EversB.M.. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.Ann Surg1998; 227: 922–31.
33.
BarnardJ.A., WarwickG.. Butyrate rapidly induces growth inhibition and differentiation in HT29 cells.Cell Growth Differ1993; 4: 495–501.
34.
HeerdtB.G., HoustonM.A., AugenlichtL.H.. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function.Cell Growth Differ1997; 8: 523–32.
35.
SaitoH., EbinumaH., TakahashiM.. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.Hepatology1998; 27: 1233–40.
36.
ZuckerS.D., GallanJ.L.. Physiology of the liver. In: HaubrichW.S., SchaffnerF., eds. Bockus Gastroenterology. Volume 3. 5th ed.Philadelphia: WB Saunders, 1995; 1858–905.
37.
NaikS., SantanginiH.A., TrenklerD.M.. Functional recovery of porcine hepatocytes after hypothermic or cryogenic preservation for liver support systems.Cell Transplant1997; 6: 447–54.
